How to Help Your Patients Find Dupixent in Stock: A Provider's Guide

For prescribers managing patients with atopic dermatitis, asthma, CRSwNP, EoE, prurigo nodularis, COPD, chronic spontaneous urticaria, bullous pemphigoid, or allergic fungal rhinosinusitis — Dupixent (dupilumab) is often the right clinical choice. Getting it into patients' hands, however, requires navigating a series of administrative and logistical hurdles that have nothing to do with clinical science.

This guide covers what works — and what doesn't — in helping patients access Dupixent efficiently in 2026.

Step 1: Initiate Prior Authorization the Day of the Prescribing Visit

The single biggest source of Dupixent access delay is PA paperwork sitting unsubmitted in the practice queue. Train your team to initiate the PA process the day of the visit — ideally before the patient leaves the building. Key actions at the point of care:

Verify the patient's insurance and identify the required specialty pharmacy at the visit

Document disease severity and step therapy completion in the note, using objective scores (EASI, IGA, ACQ, spirometry)

Prepare a letter of medical necessity — templates are available through DUPIXENT MyWay's HCP portal

Submit the prescription directly to the correct specialty pharmacy — routing errors add 3–7 days

Step 2: Know Your Plan-Specific Specialty Pharmacy Requirements

Routing a Dupixent prescription to the wrong specialty pharmacy — even a large, reputable one — can result in a weeks-long transfer or an out-of-network cost for the patient. Build a quick reference sheet for your team:

Cigna: Accredo (Express Scripts) is typically required

UnitedHealthcare: Optum Specialty is typically required

Aetna: Caremark/CVS Specialty is typically required

BCBS plans: Varies by state; confirm with DUPIXENT MyWay if uncertain

When in doubt, DUPIXENT MyWay can identify the correct specialty pharmacy for any patient's plan — call 1-844-387-4936.

Step 3: Leverage DUPIXENT MyWay's HCP Support Services

DUPIXENT MyWay provides a suite of services for healthcare providers:

Benefits investigation: Upfront coverage determination for the patient before PA submission

PA support: Assistance preparing and submitting PA documents to the payer

Appeal assistance: Templates and coordination support for first-level and peer-to-peer appeals

Bridge medication: In some cases, starter doses can be provided while PA is under review

Copay card enrollment: Eligible patients with commercial insurance may pay $0 with the MyWay Copay Card (up to $13,000/year)

Step 4: Build a PA Denial Response Protocol in Your Practice

Insurance denials for Dupixent are common — but they are not final. Establish a clear workflow in your office for when a denial occurs:

Triage the denial immediately — identify the reason and assign it to a staff member within 24 hours

Submit a first-level appeal with supplemental documentation addressing the specific denial reason

If first appeal is denied, request peer-to-peer review — the most effective tool for overturning Dupixent denials

If peer-to-peer fails, file an external independent review (required by ACA regulations for most plans)

Step 5: Set Realistic Timeline Expectations With Patients

When you decide to prescribe Dupixent, tell patients:

"This medication requires insurance approval, which typically takes 1–3 weeks."

"You may receive a call from a specialty pharmacy — please answer or return it promptly."

"If your insurance denies it, we will appeal — this is common and usually successful."

"Call DUPIXENT MyWay at 1-844-387-4936 if you haven't heard anything within two weeks."

Using medfinder to Help Patients Locate Their Specialty Pharmacy

For patients who are approved but struggling to find a specialty pharmacy that has Dupixent in stock and ready for their specific dosage and insurance plan, medfinder for providers can help. medfinder contacts specialty pharmacies on behalf of patients, identifies which ones can fill the prescription, and delivers results — saving patients from a frustrating round of calls. Recommending medfinder to your patients is a simple way to reduce follow-up calls to your office about pharmacy availability.

Monitoring and Renewal Authorization

Dupixent PAs typically require annual renewal. Build a renewal reminder into your scheduling system at the 9–10 month mark so there is no gap in authorization. At renewal, document the patient's clinical response — improvement in EASI scores, reduction in systemic corticosteroid use, or patient-reported outcomes — which supports continued authorization.